New blood tests could spare transplant patients from painful biopsies
NCT ID NCT04855422
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study is testing two blood tests, AlloSure and AlloMap, to see if they can detect organ rejection in people who have received a combined kidney and pancreas transplant. The goal is to find a less invasive way to monitor for rejection compared to the standard tissue biopsy. The study will follow 42 patients for up to three years after their transplant to see how well the blood tests work.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Blood tests (AlloSure and AlloMap)
What this could lead to
If successful, these blood tests could help doctors detect organ rejection earlier and more safely in kidney-pancreas transplant patients, reducing the need for invasive biopsies.
What could go wrong
This is a small, early pilot study with only 42 participants. The tests may not prove accurate enough to replace biopsies, and results may not apply to all transplant patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TRANSPLANT; COMPLICATION, REJECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Montefiore Medical Center
The Bronx, New York, 10461, United States